Pienta KJ - Search Results

1

The mutational landscape of lethal castration-resistant prostate cancer.

Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM, Tomlins SA. Grasso CS, et al. Among authors: pienta kj. Nature. 2012 Jul 12;487(7406):239-43. doi: 10.1038/nature11125. Nature. 2012. PMID: 22722839 Free PMC article.

2

VCaP, a cell-based model system of human prostate cancer.

Korenchuk S, Lehr JE, MClean L, Lee YG, Whitney S, Vessella R, Lin DL, Pienta KJ. Korenchuk S, et al. Among authors: pienta kj. In Vivo. 2001 Mar-Apr;15(2):163-8. In Vivo. 2001. PMID: 11317522

3

Delineation of prognostic biomarkers in prostate cancer.

Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM. Dhanasekaran SM, et al. Among authors: pienta kj. Nature. 2001 Aug 23;412(6849):822-6. doi: 10.1038/35090585. Nature. 2001. PMID: 11518967 Free article.

4

New discoveries in prostate cancer biology and treatment. 5-9 December 2001, Naples, Florida, USA.

Cooper CR, Chay CH, Pienta KJ. Cooper CR, et al. Among authors: pienta kj. Expert Opin Ther Targets. 2002 Feb;6(1):123-7. doi: 10.1517/14728222.6.1.123. Expert Opin Ther Targets. 2002. PMID: 11901478

5

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM. Rubin MA, et al. Among authors: pienta kj. JAMA. 2002 Apr 3;287(13):1662-70. doi: 10.1001/jama.287.13.1662. JAMA. 2002. PMID: 11926890

6

The polycomb group protein EZH2 is involved in progression of prostate cancer.

Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM. Varambally S, et al. Among authors: pienta kj. Nature. 2002 Oct 10;419(6907):624-9. doi: 10.1038/nature01075. Nature. 2002. PMID: 12374981 Free article. Clinical Trial.

7

A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines.

Chay CH, Cooper CR, Gendernalik JD, Dhanasekaran SM, Chinnaiyan AM, Rubin MA, Schmaier AH, Pienta KJ. Chay CH, et al. Among authors: pienta kj. Urology. 2002 Nov;60(5):760-5. doi: 10.1016/s0090-4295(02)01969-6. Urology. 2002. PMID: 12429291

8

Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.

Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS. Sun YX, et al. Among authors: pienta kj. J Cell Biochem. 2003 Jun 1;89(3):462-73. doi: 10.1002/jcb.10522. J Cell Biochem. 2003. PMID: 12761880 Free article.

9

The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer.

Kuefer R, Hofer MD, Gschwend JE, Pienta KJ, Sanda MG, Chinnaiyan AM, Rubin MA, Day ML. Kuefer R, et al. Among authors: pienta kj. Clin Cancer Res. 2003 Dec 15;9(17):6447-52. Clin Cancer Res. 2003. PMID: 14695147

10

Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.

Rubin MA, Varambally S, Beroukhim R, Tomlins SA, Rhodes DR, Paris PL, Hofer MD, Storz-Schweizer M, Kuefer R, Fletcher JA, Hsi BL, Byrne JA, Pienta KJ, Collins C, Sellers WR, Chinnaiyan AM. Rubin MA, et al. Among authors: pienta kj. Cancer Res. 2004 Jun 1;64(11):3814-22. doi: 10.1158/0008-5472.CAN-03-3881. Cancer Res. 2004. PMID: 15172988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

642 results

Search Page